Latest Market Announcements News

BPH Global has clarified the timing and rationale behind its disclosure of a binding Memorandum of Understanding with Indonesia’s National Research and Innovation Agency, confirming compliance with ASX rules.

Cobre Limited has had its trading suspension lifted immediately following the announcement of a significant acquisition and capital placement, signalling a pivotal moment for the base metals miner.

The ASX has suspended trading in Aspermont Limited, Koba Resources, and WA Kaolin due to their failure to lodge required periodic reports on time. The suspension may be lifted if the companies submit their reports promptly.

A small-cap healthcare rally had a clear centre: distribution deals, US regulatory steps, and big cheques. Osteopore, Echo IQ and Anteris led the week, while a handful of names slipped despite solid operational updates.

Neuren Pharmaceuticals has affirmed the material impact of Acadia’s projection that DAYBUE global net sales could reach approximately US$700 million by 2028, underpinning its royalty revenue outlook.

betr Entertainment has reported a robust 24.5% increase in turnover for Q2 FY26 alongside a strategic on-market share buy-back of up to 10%, signalling confidence in its intrinsic value and growth prospects.

Zoono Group Limited has responded to ASX queries confirming ongoing collaboration with OSY Group Limited, acknowledging delays in meeting sales targets but highlighting steady contract progress and future order potential.

The ASX has suspended trading of Olympio Metals and Thorney Technologies shares due to delayed periodic report filings, highlighting ongoing compliance challenges for both companies.

DroneShield Limited has clarified the recent exercise and sale of shares by its directors following performance option vesting, alongside addressing an erroneous contract announcement that was later withdrawn. The company also outlined steps to enhance compliance with ASX continuous disclosure and trading policies.

Superior Resources Limited has voluntarily suspended trading of its shares pending a Supreme Court hearing on the validation of uncleansed shares, with a prospectus filing expected to follow.

Gladiator Resources has provided detailed clarifications to the ASX regarding its agreement with Apex USA Resources LLC for rare earth tenements in California, highlighting ongoing disputes and incomplete project milestones.

Chimeric Therapeutics has responded to ASX inquiries regarding the disclosure timing and materiality of new clinical data from its ADVENT-AML trial, emphasizing compliance with continuous disclosure rules and the careful verification of promising patient responses.